OMEGA: Understanding Eosinophilic GI Diseases in Children
Official title: Clinical Trial 1: OMEGA
Funded at Cincinnati Childrens Hosp Med Ctr · NIH-11464393 · Data updated 2026-11-12
A pediatric-focused effort to better understand eosinophilic gastritis, enteritis, and colitis in kids and to find biomarkers and patient-friendly outcomes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cincinnati Childrens Hosp Med Ctr NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project start | August 15, 2014 |
| Project end | July 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $531,831 |
| NIH project number | 2U54AI117804-11 |
| Project ID | NIH-11464393 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are children with eosinophilic GI diseases (EoG, EoN, or EoC) who are enrolled in CEGRIR-related studies and have available tissue or blood samples for analysis.
✕Less likely to help
Patients without EGID or without access to the study’s biomarker and PRO data may not directly benefit.
What this research studies
This project studies rare inflammatory GI diseases in children, using data from past studies and collecting biomarkers and patient-reported outcomes to connect symptoms with tissue findings. Researchers will analyze blood, tissue samples, and other data collected during standard care to identify predictors of disease course. The goal is to find meaningful indicators that could guide future treatments and improve quality of life for affected children.
Why it matters
Potential benefit: If successful, the work could lead to better ways to track disease and inform future therapies for children with EGID.
How similar studies have gone: Previous CEGRIR cycles have identified biomarker and PRO links, suggesting this approach can yield useful insights.
Where this research is happening
-
Cincinnati Childrens Hosp Med Ctr
Cincinnati, United States Active
Researchers
- Principal investigator: Furuta, Glenn T — Cincinnati Childrens Hosp Med Ctr
- Study coordinator: Furuta, Glenn T
Related research
Other NIH-funded projects on the same topics.
-
Accelerating Rheumatic Heart Disease Prevention in Uganda
A program to find people with rheumatic heart disease in Ugandan communities and give them preventive care close to home.
-
Enhanced surveillance network to track childhood vaccines and viral infections in kids
A nationwide pediatric surveillance network will closely watch how common viruses and vaccines affect children’s health, using standard protocols at hospital and ED sites.
-
Advancing CNS drug delivery through epigenetic tweaks
A medical research project aims to help people with lysosomal storage disorders by improving how treatments reach the brain.
-
Spina Bifida Registry for Better Clinic Care
A national registry project aims to improve care for people with spina bifida by collecting and sharing data from multidisciplinary clinics to guide evidence-based practices.
-
Hydroxyurea to help children with sickle cell anemia in Africa
A pediatric study tests hydroxyurea treatment for young children with sickle cell anemia in several African countries to see if it can reduce illness and improve health.
-
Hydroxyurea for Children with Sickle Cell in Africa
A pilot study tests hydroxyurea in young children with sickle cell disease across several African countries to see if it can reduce illness and hospital visits.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.